Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Caleres, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers [1] - Caleres reported a first-quarter 2025 sales figure of $614.2 million, which is a 6.8% decline year-over-year, and the CFO acknowledged this was below expectations [3] - Following the disappointing financial results, Caleres's stock price dropped by $3.00 per share, or 18.32%, closing at $13.38 per share on May 29, 2025 [3] - The company has suspended its guidance for 2025 due to uncertainty in the business environment [3] Company Overview - Caleres, Inc. is a publicly traded company listed on the NYSE under the ticker symbol CAL [1] - The company is currently facing scrutiny from investors and legal investigations related to its business practices [1] Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [4]